---
title: "\"Performance\" CT ENTERPRISE's net profit for the first nine months was USD 23.54 million, an increase of 4.5 times"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265186917.md"
description: "CT ENTERPRISE announced its performance for the first nine months ending in September, with revenue of USD 431 million, an increase of 152.4% year-on-year; gross profit of USD 59.59 million, up 91.8%. It recorded a net profit of USD 23.54 million, a growth of 452.3%"
datetime: "2025-11-10T15:46:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265186917.md)
  - [en](https://longbridge.com/en/news/265186917.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265186917.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/265186917.md) | [繁體中文](https://longbridge.com/zh-HK/news/265186917.md)


# "Performance" CT ENTERPRISE's net profit for the first nine months was USD 23.54 million, an increase of 4.5 times

CT ENTERPRISE (03839.HK) announced its results for the first nine months ending in September, with revenue of USD 431 million, an increase of 152.4% year-on-year; gross profit of USD 59.59 million, up 91.8%. It recorded a net profit of USD 23.54 million, a growth of 452.3%

### Related Stocks

- [CT ENTERPRISE (03839.HK)](https://longbridge.com/en/quote/03839.HK.md)

## Related News & Research

- [Chia Tai Enterprises to Build New RMB28.9 Million Fermentation Facility in Henan](https://longbridge.com/en/news/279247728.md)
- [Chia Tai Forecasts Rise in 2025 Profit](https://longbridge.com/en/news/273363782.md)
- [South Korea exports rise at strongest pace in nearly four decades](https://longbridge.com/en/news/281273288.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/en/news/281325910.md)
- [CSC Financial Sticks to Their Buy Rating for Longfor Group Holdings (LNGPF)](https://longbridge.com/en/news/280898279.md)